Global Medical Plasmin Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
1 Market Overview
- 1.1 Product Overview and Scope of Medical Plasmin
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Medical Plasmin Consumption Value by Type: 2019 Versus 2023 Versus 2030
- 1.3.2 Nonspecific Plasmin
- 1.3.3 Specific Plasmin
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Medical Plasmin Consumption Value by Application: 2019 Versus 2023 Versus 2030
- 1.4.2 Disease Treatment
- 1.4.3 Biomedical Research
- 1.4.4 Others
- 1.5 Global Medical Plasmin Market Size & Forecast
- 1.5.1 Global Medical Plasmin Consumption Value (2019 & 2023 & 2030)
- 1.5.2 Global Medical Plasmin Sales Quantity (2019-2030)
- 1.5.3 Global Medical Plasmin Average Price (2019-2030)
2 Manufacturers Profiles
- 2.1 Kedrion(Prometic)
- 2.1.1 Kedrion(Prometic) Details
- 2.1.2 Kedrion(Prometic) Major Business
- 2.1.3 Kedrion(Prometic) Medical Plasmin Product and Services
- 2.1.4 Kedrion(Prometic) Medical Plasmin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.1.5 Kedrion(Prometic) Recent Developments/Updates
- 2.2 Thermo Fisher Scientific Inc.
- 2.2.1 Thermo Fisher Scientific Inc. Details
- 2.2.2 Thermo Fisher Scientific Inc. Major Business
- 2.2.3 Thermo Fisher Scientific Inc. Medical Plasmin Product and Services
- 2.2.4 Thermo Fisher Scientific Inc. Medical Plasmin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.2.5 Thermo Fisher Scientific Inc. Recent Developments/Updates
- 2.3 Merck KGaA
- 2.3.1 Merck KGaA Details
- 2.3.2 Merck KGaA Major Business
- 2.3.3 Merck KGaA Medical Plasmin Product and Services
- 2.3.4 Merck KGaA Medical Plasmin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.3.5 Merck KGaA Recent Developments/Updates
- 2.4 Genzyme Corporation (Sanofi)
- 2.4.1 Genzyme Corporation (Sanofi) Details
- 2.4.2 Genzyme Corporation (Sanofi) Major Business
- 2.4.3 Genzyme Corporation (Sanofi) Medical Plasmin Product and Services
- 2.4.4 Genzyme Corporation (Sanofi) Medical Plasmin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.4.5 Genzyme Corporation (Sanofi) Recent Developments/Updates
- 2.5 Promega Corporation
- 2.5.1 Promega Corporation Details
- 2.5.2 Promega Corporation Major Business
- 2.5.3 Promega Corporation Medical Plasmin Product and Services
- 2.5.4 Promega Corporation Medical Plasmin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.5.5 Promega Corporation Recent Developments/Updates
- 2.6 Asahi Kasei Corporation
- 2.6.1 Asahi Kasei Corporation Details
- 2.6.2 Asahi Kasei Corporation Major Business
- 2.6.3 Asahi Kasei Corporation Medical Plasmin Product and Services
- 2.6.4 Asahi Kasei Corporation Medical Plasmin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.6.5 Asahi Kasei Corporation Recent Developments/Updates
- 2.7 Takeda Pharmaceutical Company Limited
- 2.7.1 Takeda Pharmaceutical Company Limited Details
- 2.7.2 Takeda Pharmaceutical Company Limited Major Business
- 2.7.3 Takeda Pharmaceutical Company Limited Medical Plasmin Product and Services
- 2.7.4 Takeda Pharmaceutical Company Limited Medical Plasmin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.7.5 Takeda Pharmaceutical Company Limited Recent Developments/Updates
- 2.8 Cytiva (Danaher)
- 2.8.1 Cytiva (Danaher) Details
- 2.8.2 Cytiva (Danaher) Major Business
- 2.8.3 Cytiva (Danaher) Medical Plasmin Product and Services
- 2.8.4 Cytiva (Danaher) Medical Plasmin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.8.5 Cytiva (Danaher) Recent Developments/Updates
- 2.9 Agilent Technologies, Inc.
- 2.9.1 Agilent Technologies, Inc. Details
- 2.9.2 Agilent Technologies, Inc. Major Business
- 2.9.3 Agilent Technologies, Inc. Medical Plasmin Product and Services
- 2.9.4 Agilent Technologies, Inc. Medical Plasmin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.9.5 Agilent Technologies, Inc. Recent Developments/Updates
- 2.10 Sun Pharmaceutical Industries Ltd.
- 2.10.1 Sun Pharmaceutical Industries Ltd. Details
- 2.10.2 Sun Pharmaceutical Industries Ltd. Major Business
- 2.10.3 Sun Pharmaceutical Industries Ltd. Medical Plasmin Product and Services
- 2.10.4 Sun Pharmaceutical Industries Ltd. Medical Plasmin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.10.5 Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
- 2.11 Amano Enzyme Inc.
- 2.11.1 Amano Enzyme Inc. Details
- 2.11.2 Amano Enzyme Inc. Major Business
- 2.11.3 Amano Enzyme Inc. Medical Plasmin Product and Services
- 2.11.4 Amano Enzyme Inc. Medical Plasmin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.11.5 Amano Enzyme Inc. Recent Developments/Updates
- 2.12 Novozymes A/S
- 2.12.1 Novozymes A/S Details
- 2.12.2 Novozymes A/S Major Business
- 2.12.3 Novozymes A/S Medical Plasmin Product and Services
- 2.12.4 Novozymes A/S Medical Plasmin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.12.5 Novozymes A/S Recent Developments/Updates
3 Competitive Environment: Medical Plasmin by Manufacturer
- 3.1 Global Medical Plasmin Sales Quantity by Manufacturer (2019-2024)
- 3.2 Global Medical Plasmin Revenue by Manufacturer (2019-2024)
- 3.3 Global Medical Plasmin Average Price by Manufacturer (2019-2024)
- 3.4 Market Share Analysis (2023)
- 3.4.1 Producer Shipments of Medical Plasmin by Manufacturer Revenue ($MM) and Market Share (%): 2023
- 3.4.2 Top 3 Medical Plasmin Manufacturer Market Share in 2023
- 3.4.2 Top 6 Medical Plasmin Manufacturer Market Share in 2023
- 3.5 Medical Plasmin Market: Overall Company Footprint Analysis
- 3.5.1 Medical Plasmin Market: Region Footprint
- 3.5.2 Medical Plasmin Market: Company Product Type Footprint
- 3.5.3 Medical Plasmin Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Medical Plasmin Market Size by Region
- 4.1.1 Global Medical Plasmin Sales Quantity by Region (2019-2030)
- 4.1.2 Global Medical Plasmin Consumption Value by Region (2019-2030)
- 4.1.3 Global Medical Plasmin Average Price by Region (2019-2030)
- 4.2 North America Medical Plasmin Consumption Value (2019-2030)
- 4.3 Europe Medical Plasmin Consumption Value (2019-2030)
- 4.4 Asia-Pacific Medical Plasmin Consumption Value (2019-2030)
- 4.5 South America Medical Plasmin Consumption Value (2019-2030)
- 4.6 Middle East and Africa Medical Plasmin Consumption Value (2019-2030)
5 Market Segment by Type
- 5.1 Global Medical Plasmin Sales Quantity by Type (2019-2030)
- 5.2 Global Medical Plasmin Consumption Value by Type (2019-2030)
- 5.3 Global Medical Plasmin Average Price by Type (2019-2030)
6 Market Segment by Application
- 6.1 Global Medical Plasmin Sales Quantity by Application (2019-2030)
- 6.2 Global Medical Plasmin Consumption Value by Application (2019-2030)
- 6.3 Global Medical Plasmin Average Price by Application (2019-2030)
7 North America
- 7.1 North America Medical Plasmin Sales Quantity by Type (2019-2030)
- 7.2 North America Medical Plasmin Sales Quantity by Application (2019-2030)
- 7.3 North America Medical Plasmin Market Size by Country
- 7.3.1 North America Medical Plasmin Sales Quantity by Country (2019-2030)
- 7.3.2 North America Medical Plasmin Consumption Value by Country (2019-2030)
- 7.3.3 United States Market Size and Forecast (2019-2030)
- 7.3.4 Canada Market Size and Forecast (2019-2030)
- 7.3.5 Mexico Market Size and Forecast (2019-2030)
8 Europe
- 8.1 Europe Medical Plasmin Sales Quantity by Type (2019-2030)
- 8.2 Europe Medical Plasmin Sales Quantity by Application (2019-2030)
- 8.3 Europe Medical Plasmin Market Size by Country
- 8.3.1 Europe Medical Plasmin Sales Quantity by Country (2019-2030)
- 8.3.2 Europe Medical Plasmin Consumption Value by Country (2019-2030)
- 8.3.3 Germany Market Size and Forecast (2019-2030)
- 8.3.4 France Market Size and Forecast (2019-2030)
- 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
- 8.3.6 Russia Market Size and Forecast (2019-2030)
- 8.3.7 Italy Market Size and Forecast (2019-2030)
9 Asia-Pacific
- 9.1 Asia-Pacific Medical Plasmin Sales Quantity by Type (2019-2030)
- 9.2 Asia-Pacific Medical Plasmin Sales Quantity by Application (2019-2030)
- 9.3 Asia-Pacific Medical Plasmin Market Size by Region
- 9.3.1 Asia-Pacific Medical Plasmin Sales Quantity by Region (2019-2030)
- 9.3.2 Asia-Pacific Medical Plasmin Consumption Value by Region (2019-2030)
- 9.3.3 China Market Size and Forecast (2019-2030)
- 9.3.4 Japan Market Size and Forecast (2019-2030)
- 9.3.5 Korea Market Size and Forecast (2019-2030)
- 9.3.6 India Market Size and Forecast (2019-2030)
- 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
- 9.3.8 Australia Market Size and Forecast (2019-2030)
10 South America
- 10.1 South America Medical Plasmin Sales Quantity by Type (2019-2030)
- 10.2 South America Medical Plasmin Sales Quantity by Application (2019-2030)
- 10.3 South America Medical Plasmin Market Size by Country
- 10.3.1 South America Medical Plasmin Sales Quantity by Country (2019-2030)
- 10.3.2 South America Medical Plasmin Consumption Value by Country (2019-2030)
- 10.3.3 Brazil Market Size and Forecast (2019-2030)
- 10.3.4 Argentina Market Size and Forecast (2019-2030)
11 Middle East & Africa
- 11.1 Middle East & Africa Medical Plasmin Sales Quantity by Type (2019-2030)
- 11.2 Middle East & Africa Medical Plasmin Sales Quantity by Application (2019-2030)
- 11.3 Middle East & Africa Medical Plasmin Market Size by Country
- 11.3.1 Middle East & Africa Medical Plasmin Sales Quantity by Country (2019-2030)
- 11.3.2 Middle East & Africa Medical Plasmin Consumption Value by Country (2019-2030)
- 11.3.3 Turkey Market Size and Forecast (2019-2030)
- 11.3.4 Egypt Market Size and Forecast (2019-2030)
- 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
- 11.3.6 South Africa Market Size and Forecast (2019-2030)
12 Market Dynamics
- 12.1 Medical Plasmin Market Drivers
- 12.2 Medical Plasmin Market Restraints
- 12.3 Medical Plasmin Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Medical Plasmin and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Medical Plasmin
- 13.3 Medical Plasmin Production Process
- 13.4 Medical Plasmin Industrial Chain
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Medical Plasmin Typical Distributors
- 14.3 Medical Plasmin Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
According to our (Global Info Research) latest study, the global Medical Plasmin market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Plasmin refers to a proteolytic enzyme that can specifically degrade fibrin gel and is an important component in the fibrinolytic system. The coagulation and fibrinolysis systems in the body are interdependent and closely linked. Once the body generates a coagulation reaction, it also activates the fibrinolytic system almost simultaneously, removing excess thrombus in the body and reducing the level of fibrinogen in the body through a negative feedback effect, thus avoiding excessive aggregation of fibrin.
The Global Info Research report includes an overview of the development of the Medical Plasmin industry chain, the market status of Disease Treatment (Nonspecific Plasmin, Specific Plasmin), Biomedical Research (Nonspecific Plasmin, Specific Plasmin), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Medical Plasmin.
Regionally, the report analyzes the Medical Plasmin markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Medical Plasmin market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Medical Plasmin market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Medical Plasmin industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (Tons), revenue generated, and market share of different by Type (e.g., Nonspecific Plasmin, Specific Plasmin).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Medical Plasmin market.
Regional Analysis: The report involves examining the Medical Plasmin market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Medical Plasmin market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Medical Plasmin:
Company Analysis: Report covers individual Medical Plasmin manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Medical Plasmin This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Disease Treatment, Biomedical Research).
Technology Analysis: Report covers specific technologies relevant to Medical Plasmin. It assesses the current state, advancements, and potential future developments in Medical Plasmin areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Medical Plasmin market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Medical Plasmin market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Nonspecific Plasmin
Specific Plasmin
Market segment by Application
Disease Treatment
Biomedical Research
Others
Major players covered
Kedrion(Prometic)
Thermo Fisher Scientific Inc.
Merck KGaA
Genzyme Corporation (Sanofi)
Promega Corporation
Asahi Kasei Corporation
Takeda Pharmaceutical Company Limited
Cytiva (Danaher)
Agilent Technologies, Inc.
Sun Pharmaceutical Industries Ltd.
Amano Enzyme Inc.
Novozymes A/S
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Medical Plasmin product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Medical Plasmin, with price, sales, revenue and global market share of Medical Plasmin from 2019 to 2024.
Chapter 3, the Medical Plasmin competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Medical Plasmin breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Medical Plasmin market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Medical Plasmin.
Chapter 14 and 15, to describe Medical Plasmin sales channel, distributors, customers, research findings and conclusion.